rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Trane Technologies plc

TT · NYSE

Health CareLife-science toolsJust started movingData-Center Infrastructure

TT stood above a rising 150-day average in 27 of the last 52 weekly readings, including each of the last 1 week. It is 0.9% above that average now. Life Science Tools & Research Services: 54% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
1 in a row
Industry in uptrend
54% +4 in 4 wk
Insider buys, 12 months
$344K
Insider sales, 12 months
$128.5M
Officials’ trades on record
53
Institutions holding
1,731 (+62)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.

20 Apr – 19 Oct
27%44%61%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$40.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

53 disclosed lines: House 41, Senate 4, executive 8; 16 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k23 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k12 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$100k–$250k10 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorsold$15k–$50k27 Mar 2026filed 21 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1M–$5M17 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k17 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k21 Jan 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$250k–$500k6 Jan 2026filed 14 May 2026
Val T. Hoyle House: U.S. House ClerkOR04soldspouse$1k–$15k23 Sep 2025filed 10 Oct 2025
Jefferson Shreve House: U.S. House ClerkIN06sold$50k–$100k12 May 2025filed 22 Jun 2025
Jefferson Shreve House: U.S. House ClerkIN06bought$50k–$100k7 Apr 2025filed 8 May 2025
Pete Hegseth Executive branch: Office of Government EthicsDepartment of Defense/Office of The Secretarysold$1k–$15k24 Mar 2025filed 7 Jun 2025

Insiders

Buy orders, 12 months1
Sale orders, 12 months17
Buyers · sellers1 · 5
WhoDidSharesTraded
David S. RegneryChair and CEOsold48,091at $480.006 Oct 2026filed 8 Oct 2026
David S. RegneryChair and CEOsold43,778at $475.005 Aug 2026filed 6 Aug 2026
Melissa N. SchaefferDirectorsold145at $472.274 Aug 2026filed 5 Aug 2026
Donald E. SimmonsGroup President, Americassold4,593at $500.0030 Apr 2026filed 1 May 2026
Christopher J. KuehnExecutive Vice President & CFOsold8,619at $450.008 Apr 2026filed 9 Apr 2026
Donald E. SimmonsGroup President, Americassold3,762at $422.706 Mar 2026filed 9 Mar 2026
David S. RegneryChair and CEOsold36,045at $422.696 Mar 2026filed 9 Mar 2026
Elizabeth A. ElwellVP & Chief Accounting Officersold635at $422.716 Mar 2026filed 9 Mar 2026
John A. HayesDirectorbought400at $430.445 Mar 2026filed 9 Jun 2026
Donald E. SimmonsGroup President, Americassold7,663at $475.0012 Feb 2026filed 17 Feb 2026
Elizabeth A. ElwellVP & Chief Accounting Officersold137at $462.4810 Feb 2026filed 11 Feb 2026
Donald E. SimmonsGroup President, Americassold822at $462.5710 Feb 2026filed 11 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders1,731+62 on the quarter
New · exited179 · 117
Reported value$92.5B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202621,876,084$10.7B+232,012+1.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202614,437,764$7.1B+55,016+0.4%
JPMORGAN CHASE & COnew · filed 12 Aug 202612,562,815$6.0B+12,562,815
FMR LLCadded · filed 13 Aug 202610,085,086$5.0B+218,851+2.2%
STATE STREET CORPreduced · filed 7 Aug 202610,077,391$4.9B-27,468−0.3%
MORGAN STANLEYadded · filed 13 Aug 20265,415,027$2.7B+112,266+2.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20265,198,809$2.5B+12,586+0.2%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20263,591,869$1.8B+58,074+1.6%
FRANKLIN RESOURCES INCadded · filed 13 Aug 20263,293,486$1.6B+1,155,236+54.0%
Nuveen, LLCadded · filed 11 Aug 20263,013,749$1.5B+200,188+7.1%
31 Mar 2023 – 30 Jun 2026
87112851699Mar 23Dec 23Dec 24Sep 25Jun 26

News

Everyone who traded it

David S. Regnery Company insiderChair and CEO · last 6 Oct 20260 · 20
Melissa N. Schaeffer Company insiderDirector · last 4 Aug 20260 · 1
Donald E. Simmons Company insiderEVP & Chief Operating Officer · last 1 Jul 20260 · 11
Donald J. Trump Executive branchWhite House Office · last 23 Jun 20264 · 3
Ann C. Berzin Company insiderDirector · last 5 Jun 20261 · 0
Assis Ana Paula de Jesus Company insiderDirector · last 5 Jun 20260 · 0
Boise April Miller Company insiderDirector · last 5 Jun 20260 · 0
John A. Hayes Company insiderDirector · last 5 Jun 20261 · 0
John P. Surma Company insiderDirector · last 5 Jun 20261 · 0
Kirk E. Arnold Company insiderDirector · last 5 Jun 20260 · 0
Mark R. George Company insiderDirector · last 5 Jun 20260 · 0
Matthew Francis Pine Company insiderDirector · last 5 Jun 20260 · 0

Same industry

OABI OmniAbLeading+67%
TXG 10x GenomicsLeading+59%
AVTR AvantorLeading+45%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+35%
MASS 908 DevicesLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

Awards1
Total$68.3M
Latest11 Dec 2006

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202518.6%
Free cash flow marginFY 2025 · to 31 Dec 202513.2%
Return on capital employedFY 2025 · to 31 Dec 202526.2%
Cash conversionFY 2025 · to 31 Dec 2025109%
Debt to equityFY 2025 · to 31 Dec 20250.62×
Interest coverFY 2025 · to 31 Dec 202517.50×
Research spendFY 2025 · to 31 Dec 20251.6%
Share count trendFY 2025 · to 30 Jan 2026-1.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.8B
Free cash flowFY 2025 · to 31 Dec 2025$2.8B

Analyst forecasts

No analyst forecasts yet.